These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 34678524)

  • 1. Postapproval safety profile of Watchman FLX left atrial appendage occlusion device: Analysis from the MAUDE database.
    Garg J; Shah K; Pinkhas D; Bhardwaj R; Contractor T; Mandapati R; Turagam MK; Lakkireddy D
    Heart Rhythm; 2022 Feb; 19(2):332-333. PubMed ID: 34678524
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety profiles of percutaneous left atrial appendage closure devices: An analysis of the Food and Drug Administration Manufacturer and User Facility Device Experience (MAUDE) database from 2009 to 2016.
    Jazayeri MA; Vuddanda V; Turagam MK; Parikh V; Lavu M; Atkins D; Earnest M; Di Biase L; Natale A; Wilber D; Reddy YM; Lakkireddy DR
    J Cardiovasc Electrophysiol; 2018 Jan; 29(1):5-13. PubMed ID: 28988455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MAUDE Database Analysis of Post-Approval Outcomes following Left Atrial Appendage Closure with the Watchman Device.
    Ledesma PA; Uzomah UA; Yu X; Shaqdan A; Khaloo P; Galvin J; Mansour M; Ptaszek LM; Ruskin JN
    Am J Cardiol; 2021 Aug; 152():78-87. PubMed ID: 34116792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postapproval Community Hospital Experience in the United States with Left Atrial Appendage Closure Device (Watchman).
    Khalighi K; Sharma M; Masih R; Levin V
    J Stroke Cerebrovasc Dis; 2018 Sep; 27(9):2538-2542. PubMed ID: 29857929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse Events After Left Atrial Appendage Closure: Lessons Learned From the Manufacturer and User Facility Device Experience (MAUDE) Database.
    Heaton J; Okoh AK; Sossou C; Singh S; Sandhu M; Chakrabarti R; Rao R; Waxman S; Tayal R; Wasty N
    J Invasive Cardiol; 2020 Aug; 32(8):E216-E218. PubMed ID: 32737269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Watchman saga--closure at last?
    Kramer DB; Kesselheim AS
    N Engl J Med; 2015 Mar; 372(11):994-5. PubMed ID: 25760353
    [No Abstract]   [Full Text] [Related]  

  • 7. Overview of the Food and Drug Administration circulatory system devices panel meetings on WATCHMAN left atrial appendage closure therapy.
    Waksman R; Pendyala LK
    Am J Cardiol; 2015 Feb; 115(3):378-84. PubMed ID: 25579887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left atrial catheter ablation subsequent to Watchman® left atrial appendage device implantation: a single centre experience.
    Walker DT; Phillips KP
    Europace; 2015 Sep; 17(9):1402-6. PubMed ID: 25999186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical device regulatory reform: insights from the watchman left atrial appendage closure technology for stroke prophylaxis in atrial fibrillation.
    Cingolani E; Stevens S; Shehata M; Diamond GA; Kaul S
    Arch Intern Med; 2011 Oct; 171(18):1670-2. PubMed ID: 21746999
    [No Abstract]   [Full Text] [Related]  

  • 10. Intracardiac echocardiography- versus transesophageal echocardiography-guided left atrial appendage occlusion with Watchman FLX.
    Gianni C; Horton RP; Della Rocca DG; Mohanty S; Al-Ahmad A; Bassiouny MA; Burkhardt JD; Gallinghouse GJ; Hranitzky PM; Sanchez JE; Natale A
    J Cardiovasc Electrophysiol; 2021 Oct; 32(10):2781-2784. PubMed ID: 34411376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left atrial appendage closure in patients with prohibitive anatomy: Insights from PINNACLE FLX.
    Ellis CR; Jackson GG; Kanagasundram AN; Mansour M; Sutton B; Houle VM; Kar S; Doshi S; Osorio J
    Heart Rhythm; 2021 Jul; 18(7):1153-1161. PubMed ID: 33957090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left atrial thrombus two years after placement of a left atrial appendage closure device: Unexplored area of the Watchman.
    Yoo DH; Clark B; Nguyen D; Dickfeld TM; Zohlman AS; Wang L; See VY
    Pacing Clin Electrophysiol; 2018 Jul; 41(7):870-871. PubMed ID: 29746708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial.
    Reddy VY; Doshi SK; Sievert H; Buchbinder M; Neuzil P; Huber K; Halperin JL; Holmes D;
    Circulation; 2013 Feb; 127(6):720-9. PubMed ID: 23325525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracardiac echocardiography-guided implantation of the Watchman FLX left atrial appendage closure device.
    Turagam MK; Neuzil P; Petru J; Hala P; Mraz T; Baroch J; Lekesova V; Prokopova M; Dukkipati SR; Reddy VY
    J Cardiovasc Electrophysiol; 2021 Mar; 32(3):717-725. PubMed ID: 33533089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The PROTECT AF (WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients with Atrial Fibrillation) trial.
    Fountain RB; Holmes DR; Chandrasekaran K; Packer D; Asirvatham S; Van Tassel R; Turi Z
    Am Heart J; 2006 May; 151(5):956-61. PubMed ID: 16644311
    [No Abstract]   [Full Text] [Related]  

  • 16. Multiple Thromboembolic Events from a Left Atrial Appendage Occlusion Device.
    Prosperi-Porta G; Schnell G; Colbert J; Franko A; Wilton SB; Kuriachan VP
    Can J Cardiol; 2018 Mar; 34(3):342.e13-342.e15. PubMed ID: 29475536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postapproval Safety Profiles of Different Implantable Cardiac Monitor Devices (from a Food and Drug Administration MAUDE Database Study).
    Kewcharoen J; Shah K; Bhardwaj R; Contractor T; Turagam MK; Mandapati R; Lakkireddy D; Garg J
    Am J Cardiol; 2022 Sep; 178():173-174. PubMed ID: 35803778
    [No Abstract]   [Full Text] [Related]  

  • 18. The WATCHMAN left atrial appendage closure device for atrial fibrillation.
    Möbius-Winkler S; Sandri M; Mangner N; Lurz P; Dähnert I; Schuler G
    J Vis Exp; 2012 Feb; (60):. PubMed ID: 22395336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the WATCHMAN left atrial appendage closure device.
    Alli O; Holmes D
    Expert Rev Med Devices; 2014 Nov; 11(6):541-51. PubMed ID: 25060590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudy.
    Viles-Gonzalez JF; Kar S; Douglas P; Dukkipati S; Feldman T; Horton R; Holmes D; Reddy VY
    J Am Coll Cardiol; 2012 Mar; 59(10):923-9. PubMed ID: 22381428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.